Taiwan Advanced Nanotech Inc.
Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plat… Read more
Taiwan Advanced Nanotech Inc. (6797) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.021x
Based on the latest financial reports, Taiwan Advanced Nanotech Inc. (6797) has a cash flow conversion efficiency ratio of -0.021x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-18.29 Million) by net assets (NT$888.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Taiwan Advanced Nanotech Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Taiwan Advanced Nanotech Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Taiwan Advanced Nanotech Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Taiwan Advanced Nanotech Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chromocell Therapeutics Corporation
NYSE MKT:CHRO
|
0.069x |
|
JCBNext Berhad Bhd
KLSE:0058
|
0.008x |
|
artnet AG
PINK:ARTZF
|
0.708x |
|
Daewon Co. Ltd
KQ:007680
|
0.059x |
|
Cosmos Health Inc.
NASDAQ:COSM
|
-0.172x |
|
Artha Optimum A/S
CO:ARAOPT
|
N/A |
|
EAST STAR RES.PLC LS-01
F:5MM
|
N/A |
|
FORIS AG
F:FRS
|
-0.100x |
Annual Cash Flow Conversion Efficiency for Taiwan Advanced Nanotech Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Taiwan Advanced Nanotech Inc. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.01 Billion | NT$-18.80 Million | -0.019x | +92.98% |
| 2023-12-31 | NT$1.19 Billion | NT$-317.24 Million | -0.266x | -198.82% |
| 2022-12-31 | NT$1.51 Billion | NT$406.64 Million | 0.269x | -51.24% |
| 2021-12-31 | NT$1.28 Billion | NT$703.42 Million | 0.552x | -25.65% |
| 2020-12-31 | NT$948.11 Million | NT$703.35 Million | 0.742x | +540.49% |
| 2019-12-31 | NT$147.42 Million | NT$-24.83 Million | -0.168x | -- |